Trial of Shaladi Churna in the management of Diabetes Mellitus
Phase 3
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/06/054215
- Lead Sponsor
- Dr Kalyani Thote
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Age group: between 30 years to 60 years.
2) Gender: Male and Female both will be included.
3) A known Diabetic on treatment and newly diagnosed Diabetes.
4) Patient with fasting blood sugar up to 220 mg/dl & post prandial blood sugar upto 300 mg/dl.
5) Patient having HbA1c in between 7 to 9 and Sr. Insulin.
Exclusion Criteria
1) IDDM, Acromegaly, Cushingâ??s syndrome and pancreatic disorder.
2) Pregnant and lactating mothers.
3) Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.
4) Patients with gastrointestinal diseases, Liver diseases, tumours, cardio vascular disease, acute myocardial infarction, immune-compromised disease(HIV).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycosylated hemoglobin <br/ ><br>Blood Sugar levels <br/ ><br>Timepoint: at baseline, 4 weeks, 8 weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI